Camillo Ricordi is a Pancreatic function and diabetes physician affiliated with Miami Transplant Institute. OpenAlex indexes 1,084 publications with 48,367 citations (h-index 106); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 15 Oct 2026
Camillo Ricordi, MD, is affiliated with Miami Transplant Institute. The public record shows 1,084 publications with 48,367 citations (h-index 106), centered on Pancreatic function and diabetes, Diabetes and associated disorders, Diabetes Management and Research. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 3 companies, 9 NIH-funded awards (1996–2014).
- Most recent indexed publication: 2026 · Nutrients
- Top research focus: Pancreatic function and diabetes
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 528.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Breakthrough - T1DM and Chronic Kidney Disease
Sponsor: University of Chicago
- Use of UC-MSCs for COVID-19 Patients
Sponsor: Camillo Ricordi
- Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
Sponsor: Rodolfo Alejandro
Industry payments
Updated 15 Oct 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20252 payments$48,500openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year20255 payments$24,675openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year20243 payments$13,850openpaymentsdata.cms.gov ↗
NIH funding
Updated 15 Oct 2026
9 NIH research awards on record, funded 1996–2014 per NIH RePORTER. The latest:
- A perfluorocarbon-based culture device for beta cell biology applications (Phase
Ophysio, Inc.
FY2013$396,237R44DK083832
Congress activity
Updated 15 Oct 2026
11 congress contributions (1989–2020) across ADA, ASCO per OpenAlex. The most recent:
- 118-OR: HLA Matching and Clinical Outcomes in Islet Transplantation
ADA Scientific Sessions
ADA2020Co-authorOral - 206-LB: Survival after Islet Transplantation in Subjects with Type 1 Diabetes: 20-Year Follow-Up
ADA Scientific Sessions
ADA2020Presenting authorLate-breaking - 2290-PUB: Donor HLA-DR4 Positivity and Islet Transplantation Outcomes
ADA Scientific Sessions
ADA2020Co-authorOnline-only
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Choosing the right calcium channel blocker for patients with hypertension and proteinuric chronic kidney disease.
Current medical research and opinion
Review2025 - The unique pathophysiological features of diabetes mellitus secondary to total pancreatectomy: proposal for a new classification distinct from diabetes of the exocrine pancreas.
Expert review of endocrinology & metabolism
Article2023
Most-cited works
by citation count (OpenAlex)- 01International Trial of the Edmonton Protocol for Islet TransplantationArticle1,946 citations2006
- 02Automated Method for Isolation of Human Pancreatic IsletsArticle1,306 citations1988
- 03The unique cytoarchitecture of human pancreatic islets has implications for islet cell functionArticle1,293 citations2006
- 04Cell migration, chimerism, and graft acceptanceArticle1,072 citations1992
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Facebook
facebook.com/camillo.ricordi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/camilloricordimdofficial
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/in/camillo-ricordi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
fit4healthspan.org
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fit4healthspan.org ↗ - ResearchGate
researchgate.net/profile/Camillo-Ricordi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/CamilloRicordi
Mentions by others
where others cite or feature them- Other
med.miami.edu/faculty/camillo-ricordi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH